Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of Autophagy Reveals ATR Protein Kinase as a Key Mediator of Cisplatin Sensitivity in Osteosarcoma.

Cancer medicine·2026
Same author

Generation and characterization of an immortalized equine osteoblast cell line.

Veterinary journal (London, England : 1997)·2026
Same author

Localized growth factor delivery from microparticles modulates osteogenic and chondrogenic gene expression in a growth factor-dependent manner in an ex vivo chick embryonic bone model.

Acta biomaterialia·2025
Same author

<i>In vivo</i> analysis of hybrid hydrogels containing dual growth factor combinations, and skeletal stem cells under mechanical stimulation for bone repair.

Mechanobiology in medicine·2025
Same author

Porcupine inhibition is a promising pharmacological treatment for severe sclerosteosis pathologies.

Bone research·2025
Same author

Neurosurgical application of olaparib from a thermo-responsive paste potentiates DNA damage to prolong survival in malignant glioma.

British journal of cancer·2024

Related Experiment Video

Updated: Jun 20, 2026

Generation of Aggregates of Mouse Embryonic Stem Cells that Show Symmetry Breaking, Polarization and Emergent Collective Behaviour In Vitro
11:37

Generation of Aggregates of Mouse Embryonic Stem Cells that Show Symmetry Breaking, Polarization and Emergent Collective Behaviour In Vitro

Published on: November 24, 2015

Engineering embryonic stem-cell aggregation allows an enhanced osteogenic differentiation in vitro.

David Gothard1, Scott J Roberts, Kevin M Shakesheff

  • 1Division of Drug Delivery and Tissue Engineering, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom.

Tissue Engineering. Part C, Methods
|September 16, 2009
PubMed
Summary

Engineered embryonic stem cell (ES) cultures show improved osteogenic differentiation for bone tissue repair. This 3D system enhances mesoderm homogeneity, leading to more efficient bone cell development.

More Related Videos

Aggregate Size Optimization in Microwells for Suspension-based Cardiac Differentiation of Human Pluripotent Stem Cells
06:28

Aggregate Size Optimization in Microwells for Suspension-based Cardiac Differentiation of Human Pluripotent Stem Cells

Published on: September 25, 2016

Related Experiment Videos

Last Updated: Jun 20, 2026

Generation of Aggregates of Mouse Embryonic Stem Cells that Show Symmetry Breaking, Polarization and Emergent Collective Behaviour In Vitro
11:37

Generation of Aggregates of Mouse Embryonic Stem Cells that Show Symmetry Breaking, Polarization and Emergent Collective Behaviour In Vitro

Published on: November 24, 2015

Aggregate Size Optimization in Microwells for Suspension-based Cardiac Differentiation of Human Pluripotent Stem Cells
06:28

Aggregate Size Optimization in Microwells for Suspension-based Cardiac Differentiation of Human Pluripotent Stem Cells

Published on: September 25, 2016

Area of Science:

  • Stem cell biology
  • Tissue engineering
  • Regenerative medicine

Background:

  • Embryonic stem (ES) cells are promising for tissue engineering, but osteogenic differentiation is inefficient and yields heterogeneous cell populations.
  • Previous methods involved dissociated embryoid body (EB) culture in osteoinductive media for bone regeneration applications.
  • An engineered 3D culture system was developed for controlled ES cell-ES cell interactions.

Purpose of the Study:

  • To investigate the impact of an engineered 3D culture system on ES cell osteogenic differentiation.
  • To assess if controlled ES cell aggregation enhances bone cell development compared to traditional methods.

Main Methods:

  • Engineered embryoid bodies (EBs) were created using an avidin-biotin binding complex for controlled cell-cell interaction.
  • Engineered EBs were cultured in both osteoinductive and control media.
  • Osteogenic differentiation was assessed via gene expression (cadherin-11, Runx2, osteopontin), alkaline phosphatase activity, and bone nodule formation.
  • Polymerase chain reaction (PCR) analyzed germ layer gene expression.

Main Results:

  • Engineered EBs demonstrated enhanced osteogenic differentiation markers compared to controls.
  • Cultures from intact EBs aggregated for 3 days showed the highest osteogenic differentiation in osteoinductive media.
  • Bone nodule formation was observed in engineered samples even in control media.
  • Engineered samples showed reduced endoderm and ectoderm gene expression, indicating increased mesoderm homogeneity.

Conclusions:

  • Engineered ES cell aggregation in a 3D system significantly improves osteogenic differentiation efficiency.
  • This approach promotes mesoderm homogeneity, leading to more robust bone cell development.
  • The engineered system holds potential for bone tissue repair, regeneration, and pharmacological applications.